Typical escalation Safety first Semaglutide is an effective medicine and like any medicine it carries risks
The FDA has also reported concerns about dosing errors and improper refrigeration during shipping for some compounded injectable GLP-1 products
Based on published phase 2 clinical trial data, the most commonly reported adverse effects include: Gastrointestinal effects: Nausea, vomiting, diarrhoea, constipation, and reduced appetite are the most frequently reported side effects
Fat in the liver is a huge risk for obese people and it ties into wider metabolic concerns
Supports red blood cell production and overall metabolic health
Severe skin reactions: Serious, potentially fatal skin issues, including Stevens-Johnson Syndrome and toxic epidermal necrolysis (TEN), may occur when you take acetaminophen